nodes	percent_of_prediction	percent_of_DWPC	metapath
Boceprevir—ABCB1—Lisinopril—dilated cardiomyopathy	0.135	0.532	CbGbCtD
Boceprevir—ABCB1—Spironolactone—dilated cardiomyopathy	0.119	0.468	CbGbCtD
Boceprevir—CMA1—ACE Inhibitor Pathway—MAS1—dilated cardiomyopathy	0.0353	0.127	CbGpPWpGaD
Boceprevir—CMA1—ACE Inhibitor Pathway—NR3C2—dilated cardiomyopathy	0.0275	0.0989	CbGpPWpGaD
Boceprevir—Orthopnoea—Lisinopril—dilated cardiomyopathy	0.0246	0.0686	CcSEcCtD
Boceprevir—CMA1—ACE Inhibitor Pathway—AGTR2—dilated cardiomyopathy	0.0148	0.0534	CbGpPWpGaD
Boceprevir—CTSL—cardiac ventricle—dilated cardiomyopathy	0.0147	0.134	CbGeAlD
Boceprevir—CTSL—myocardium—dilated cardiomyopathy	0.0138	0.126	CbGeAlD
Boceprevir—CMA1—Metabolism of Angiotensinogen to Angiotensins—ACE—dilated cardiomyopathy	0.0133	0.0478	CbGpPWpGaD
Boceprevir—CMA1—ACE Inhibitor Pathway—ACE—dilated cardiomyopathy	0.0127	0.0456	CbGpPWpGaD
Boceprevir—CMA1—ACE Inhibitor Pathway—AGTR1—dilated cardiomyopathy	0.0114	0.041	CbGpPWpGaD
Boceprevir—CMA1—heart—dilated cardiomyopathy	0.0113	0.103	CbGeAlD
Boceprevir—Acute myocardial infarction—Lisinopril—dilated cardiomyopathy	0.0112	0.0313	CcSEcCtD
Boceprevir—CTSK—cardiac ventricle—dilated cardiomyopathy	0.011	0.101	CbGeAlD
Boceprevir—CTSK—myocardium—dilated cardiomyopathy	0.0104	0.0953	CbGeAlD
Boceprevir—CTSL—heart—dilated cardiomyopathy	0.00963	0.0883	CbGeAlD
Boceprevir—CTSS—myocardium—dilated cardiomyopathy	0.00911	0.0835	CbGeAlD
Boceprevir—CMA1—Metabolism of Angiotensinogen to Angiotensins—AGT—dilated cardiomyopathy	0.00843	0.0303	CbGpPWpGaD
Boceprevir—CTSL—cardiac atrium—dilated cardiomyopathy	0.00823	0.0755	CbGeAlD
Boceprevir—Drug eruption—Spironolactone—dilated cardiomyopathy	0.00816	0.0228	CcSEcCtD
Boceprevir—CMA1—ACE Inhibitor Pathway—AGT—dilated cardiomyopathy	0.00803	0.0289	CbGpPWpGaD
Boceprevir—CTSK—heart—dilated cardiomyopathy	0.00725	0.0665	CbGeAlD
Boceprevir—CTSL—Primary Focal Segmental Glomerulosclerosis FSGS—VCL—dilated cardiomyopathy	0.00706	0.0254	CbGpPWpGaD
Boceprevir—Skin infection—Lisinopril—dilated cardiomyopathy	0.00679	0.0189	CcSEcCtD
Boceprevir—Rash erythematous—Spironolactone—dilated cardiomyopathy	0.00656	0.0183	CcSEcCtD
Boceprevir—CTSS—heart—dilated cardiomyopathy	0.00636	0.0583	CbGeAlD
Boceprevir—CTSL—Degradation of the extracellular matrix—PSEN1—dilated cardiomyopathy	0.00621	0.0224	CbGpPWpGaD
Boceprevir—CTSV—Degradation of the extracellular matrix—PSEN1—dilated cardiomyopathy	0.00621	0.0224	CbGpPWpGaD
Boceprevir—CTSK—cardiac atrium—dilated cardiomyopathy	0.0062	0.0569	CbGeAlD
Boceprevir—CMA1—Degradation of the extracellular matrix—PSEN1—dilated cardiomyopathy	0.00578	0.0208	CbGpPWpGaD
Boceprevir—Amenorrhoea—Spironolactone—dilated cardiomyopathy	0.00571	0.0159	CcSEcCtD
Boceprevir—CTSK—Degradation of the extracellular matrix—PSEN1—dilated cardiomyopathy	0.00515	0.0185	CbGpPWpGaD
Boceprevir—Drug eruption—Furosemide—dilated cardiomyopathy	0.00444	0.0124	CcSEcCtD
Boceprevir—Cerebral ischaemia—Lisinopril—dilated cardiomyopathy	0.00424	0.0118	CcSEcCtD
Boceprevir—CTSS—Degradation of the extracellular matrix—PSEN1—dilated cardiomyopathy	0.00424	0.0153	CbGpPWpGaD
Boceprevir—Blood triglycerides increased—Furosemide—dilated cardiomyopathy	0.00417	0.0116	CcSEcCtD
Boceprevir—CTSV—Extracellular matrix organization—LAMA4—dilated cardiomyopathy	0.00387	0.0139	CbGpPWpGaD
Boceprevir—CTSL—Extracellular matrix organization—LAMA4—dilated cardiomyopathy	0.00387	0.0139	CbGpPWpGaD
Boceprevir—Apathy—Furosemide—dilated cardiomyopathy	0.00382	0.0107	CcSEcCtD
Boceprevir—Flat affect—Furosemide—dilated cardiomyopathy	0.00379	0.0106	CcSEcCtD
Boceprevir—Lethargy—Spironolactone—dilated cardiomyopathy	0.00372	0.0104	CcSEcCtD
Boceprevir—CMA1—Extracellular matrix organization—LAMA4—dilated cardiomyopathy	0.0036	0.013	CbGpPWpGaD
Boceprevir—CTSL—Primary Focal Segmental Glomerulosclerosis FSGS—ITGB1—dilated cardiomyopathy	0.00354	0.0127	CbGpPWpGaD
Boceprevir—CMA1—Peptide hormone metabolism—ACE—dilated cardiomyopathy	0.00349	0.0126	CbGpPWpGaD
Boceprevir—Psoriasis—Lisinopril—dilated cardiomyopathy	0.00326	0.0091	CcSEcCtD
Boceprevir—Gastritis—Spironolactone—dilated cardiomyopathy	0.00323	0.009	CcSEcCtD
Boceprevir—CTSK—Extracellular matrix organization—LAMA4—dilated cardiomyopathy	0.00321	0.0115	CbGpPWpGaD
Boceprevir—Disturbance in attention—Furosemide—dilated cardiomyopathy	0.00315	0.0088	CcSEcCtD
Boceprevir—Eosinophilia—Spironolactone—dilated cardiomyopathy	0.00312	0.0087	CcSEcCtD
Boceprevir—Hyperuricaemia—Furosemide—dilated cardiomyopathy	0.00294	0.00822	CcSEcCtD
Boceprevir—CTSK—RANKL/RANK Signaling Pathway—RAC1—dilated cardiomyopathy	0.00293	0.0105	CbGpPWpGaD
Boceprevir—Gout—Furosemide—dilated cardiomyopathy	0.00293	0.00816	CcSEcCtD
Boceprevir—Erectile dysfunction—Spironolactone—dilated cardiomyopathy	0.0029	0.00809	CcSEcCtD
Boceprevir—Hearing impaired—Furosemide—dilated cardiomyopathy	0.00287	0.00801	CcSEcCtD
Boceprevir—Stevens-Johnson syndrome—Spironolactone—dilated cardiomyopathy	0.00278	0.00777	CcSEcCtD
Boceprevir—Blood uric acid increased—Furosemide—dilated cardiomyopathy	0.00278	0.00776	CcSEcCtD
Boceprevir—CTSL—Antigen processing-Cross presentation—CD36—dilated cardiomyopathy	0.00278	0.01	CbGpPWpGaD
Boceprevir—CTSV—Antigen processing-Cross presentation—CD36—dilated cardiomyopathy	0.00278	0.01	CbGpPWpGaD
Boceprevir—CTSS—Extracellular matrix organization—LAMA4—dilated cardiomyopathy	0.00264	0.00951	CbGpPWpGaD
Boceprevir—Otitis media—Lisinopril—dilated cardiomyopathy	0.00263	0.00735	CcSEcCtD
Boceprevir—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.00262	0.00731	CcSEcCtD
Boceprevir—Memory impairment—Lisinopril—dilated cardiomyopathy	0.00261	0.00729	CcSEcCtD
Boceprevir—CTSV—Extracellular matrix organization—PSEN1—dilated cardiomyopathy	0.0026	0.00937	CbGpPWpGaD
Boceprevir—CTSL—Extracellular matrix organization—PSEN1—dilated cardiomyopathy	0.0026	0.00937	CbGpPWpGaD
Boceprevir—CTSV—Extracellular matrix organization—DMD—dilated cardiomyopathy	0.00257	0.00923	CbGpPWpGaD
Boceprevir—CTSL—Extracellular matrix organization—DMD—dilated cardiomyopathy	0.00257	0.00923	CbGpPWpGaD
Boceprevir—Endocrine disorder—Lisinopril—dilated cardiomyopathy	0.00247	0.0069	CcSEcCtD
Boceprevir—CMA1—Extracellular matrix organization—PSEN1—dilated cardiomyopathy	0.00242	0.00871	CbGpPWpGaD
Boceprevir—CMA1—Extracellular matrix organization—DMD—dilated cardiomyopathy	0.00239	0.00858	CbGpPWpGaD
Boceprevir—Erythema multiforme—Spironolactone—dilated cardiomyopathy	0.00238	0.00665	CcSEcCtD
Boceprevir—Mental disability—Furosemide—dilated cardiomyopathy	0.00237	0.00661	CcSEcCtD
Boceprevir—Chest discomfort—Lisinopril—dilated cardiomyopathy	0.00232	0.00646	CcSEcCtD
Boceprevir—Diabetes mellitus—Furosemide—dilated cardiomyopathy	0.00228	0.00636	CcSEcCtD
Boceprevir—Oropharyngeal pain—Lisinopril—dilated cardiomyopathy	0.00225	0.00629	CcSEcCtD
Boceprevir—Alopecia—Spironolactone—dilated cardiomyopathy	0.00223	0.00622	CcSEcCtD
Boceprevir—Deafness—Furosemide—dilated cardiomyopathy	0.00222	0.00618	CcSEcCtD
Boceprevir—CMA1—Peptide hormone metabolism—AGT—dilated cardiomyopathy	0.00221	0.00797	CbGpPWpGaD
Boceprevir—Gout—Lisinopril—dilated cardiomyopathy	0.00219	0.00612	CcSEcCtD
Boceprevir—CTSK—Extracellular matrix organization—PSEN1—dilated cardiomyopathy	0.00216	0.00776	CbGpPWpGaD
Boceprevir—CTSK—Extracellular matrix organization—DMD—dilated cardiomyopathy	0.00213	0.00765	CbGpPWpGaD
Boceprevir—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.00211	0.00589	CcSEcCtD
Boceprevir—Dermatitis exfoliative—Furosemide—dilated cardiomyopathy	0.0021	0.00586	CcSEcCtD
Boceprevir—Neck pain—Lisinopril—dilated cardiomyopathy	0.00207	0.00579	CcSEcCtD
Boceprevir—Musculoskeletal pain—Lisinopril—dilated cardiomyopathy	0.00207	0.00579	CcSEcCtD
Boceprevir—Pulmonary embolism—Lisinopril—dilated cardiomyopathy	0.00205	0.00572	CcSEcCtD
Boceprevir—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.00204	0.00568	CcSEcCtD
Boceprevir—Lethargy—Furosemide—dilated cardiomyopathy	0.00202	0.00565	CcSEcCtD
Boceprevir—Influenza like illness—Lisinopril—dilated cardiomyopathy	0.00199	0.00555	CcSEcCtD
Boceprevir—Wheezing—Lisinopril—dilated cardiomyopathy	0.00199	0.00555	CcSEcCtD
Boceprevir—Salivary hypersecretion—Lisinopril—dilated cardiomyopathy	0.00199	0.00555	CcSEcCtD
Boceprevir—Malaise—Spironolactone—dilated cardiomyopathy	0.00198	0.00552	CcSEcCtD
Boceprevir—Leukopenia—Spironolactone—dilated cardiomyopathy	0.00196	0.00548	CcSEcCtD
Boceprevir—CMA1—Metabolism of proteins—TAZ—dilated cardiomyopathy	0.00194	0.00699	CbGpPWpGaD
Boceprevir—CMA1—Metabolism of proteins—ZBTB17—dilated cardiomyopathy	0.00194	0.00699	CbGpPWpGaD
Boceprevir—Photophobia—Lisinopril—dilated cardiomyopathy	0.00192	0.00537	CcSEcCtD
Boceprevir—CTSS—Antigen processing-Cross presentation—CD36—dilated cardiomyopathy	0.0019	0.00682	CbGpPWpGaD
Boceprevir—Irritability—Furosemide—dilated cardiomyopathy	0.00189	0.00528	CcSEcCtD
Boceprevir—Discomfort—Spironolactone—dilated cardiomyopathy	0.00185	0.00515	CcSEcCtD
Boceprevir—Dehydration—Furosemide—dilated cardiomyopathy	0.00184	0.00515	CcSEcCtD
Boceprevir—Confusional state—Spironolactone—dilated cardiomyopathy	0.00181	0.00504	CcSEcCtD
Boceprevir—Hypokalaemia—Furosemide—dilated cardiomyopathy	0.0018	0.00503	CcSEcCtD
Boceprevir—CTSS—Extracellular matrix organization—PSEN1—dilated cardiomyopathy	0.00178	0.00639	CbGpPWpGaD
Boceprevir—CTSL—Toll-Like Receptors Cascades—CD36—dilated cardiomyopathy	0.00177	0.00635	CbGpPWpGaD
Boceprevir—CTSV—Toll-Like Receptors Cascades—CD36—dilated cardiomyopathy	0.00177	0.00635	CbGpPWpGaD
Boceprevir—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.00175	0.00489	CcSEcCtD
Boceprevir—CTSS—Extracellular matrix organization—DMD—dilated cardiomyopathy	0.00175	0.0063	CbGpPWpGaD
Boceprevir—Muscular weakness—Furosemide—dilated cardiomyopathy	0.00175	0.00488	CcSEcCtD
Boceprevir—Abdominal distension—Furosemide—dilated cardiomyopathy	0.00173	0.00481	CcSEcCtD
Boceprevir—Sleep disorder—Lisinopril—dilated cardiomyopathy	0.00172	0.0048	CcSEcCtD
Boceprevir—Diabetes mellitus—Lisinopril—dilated cardiomyopathy	0.00171	0.00477	CcSEcCtD
Boceprevir—Eosinophilia—Furosemide—dilated cardiomyopathy	0.0017	0.00473	CcSEcCtD
Boceprevir—ABCB1—ABC-family proteins mediated transport—ABCC9—dilated cardiomyopathy	0.0017	0.0061	CbGpPWpGaD
Boceprevir—Pancreatitis—Furosemide—dilated cardiomyopathy	0.00168	0.00469	CcSEcCtD
Boceprevir—Gastroenteritis—Lisinopril—dilated cardiomyopathy	0.00168	0.00468	CcSEcCtD
Boceprevir—Eczema—Lisinopril—dilated cardiomyopathy	0.00166	0.00462	CcSEcCtD
Boceprevir—Nasal congestion—Lisinopril—dilated cardiomyopathy	0.00163	0.00456	CcSEcCtD
Boceprevir—Pollakiuria—Furosemide—dilated cardiomyopathy	0.00158	0.00442	CcSEcCtD
Boceprevir—Atrial fibrillation—Lisinopril—dilated cardiomyopathy	0.00157	0.00438	CcSEcCtD
Boceprevir—Photosensitivity reaction—Furosemide—dilated cardiomyopathy	0.00156	0.00436	CcSEcCtD
Boceprevir—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00155	0.00431	CcSEcCtD
Boceprevir—CMA1—Signaling by SCF-KIT—RAC1—dilated cardiomyopathy	0.00155	0.00556	CbGpPWpGaD
Boceprevir—Hyperglycaemia—Furosemide—dilated cardiomyopathy	0.00155	0.00431	CcSEcCtD
Boceprevir—Arthritis—Lisinopril—dilated cardiomyopathy	0.00153	0.00427	CcSEcCtD
Boceprevir—Stevens-Johnson syndrome—Furosemide—dilated cardiomyopathy	0.00151	0.00423	CcSEcCtD
Boceprevir—Pain in extremity—Lisinopril—dilated cardiomyopathy	0.00149	0.00415	CcSEcCtD
Boceprevir—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00148	0.00412	CcSEcCtD
Boceprevir—CTSK—Toll-Like Receptors Cascades—CD36—dilated cardiomyopathy	0.00146	0.00526	CbGpPWpGaD
Boceprevir—Hepatobiliary disease—Furosemide—dilated cardiomyopathy	0.00145	0.00403	CcSEcCtD
Boceprevir—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.00143	0.00398	CcSEcCtD
Boceprevir—Urticaria—Spironolactone—dilated cardiomyopathy	0.00142	0.00397	CcSEcCtD
Boceprevir—Irritability—Lisinopril—dilated cardiomyopathy	0.00142	0.00396	CcSEcCtD
Boceprevir—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00142	0.00395	CcSEcCtD
Boceprevir—Dehydration—Lisinopril—dilated cardiomyopathy	0.00138	0.00386	CcSEcCtD
Boceprevir—Urinary tract disorder—Furosemide—dilated cardiomyopathy	0.00135	0.00378	CcSEcCtD
Boceprevir—Urethral disorder—Furosemide—dilated cardiomyopathy	0.00134	0.00375	CcSEcCtD
Boceprevir—Breast disorder—Lisinopril—dilated cardiomyopathy	0.00134	0.00375	CcSEcCtD
Boceprevir—Nasopharyngitis—Lisinopril—dilated cardiomyopathy	0.00133	0.00371	CcSEcCtD
Boceprevir—Visual impairment—Furosemide—dilated cardiomyopathy	0.00132	0.00369	CcSEcCtD
Boceprevir—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00132	0.00368	CcSEcCtD
Boceprevir—Gastritis—Lisinopril—dilated cardiomyopathy	0.00132	0.00367	CcSEcCtD
Boceprevir—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.0013	0.00362	CcSEcCtD
Boceprevir—Influenza—Lisinopril—dilated cardiomyopathy	0.00129	0.00359	CcSEcCtD
Boceprevir—Eye disorder—Furosemide—dilated cardiomyopathy	0.00128	0.00358	CcSEcCtD
Boceprevir—Tinnitus—Furosemide—dilated cardiomyopathy	0.00128	0.00357	CcSEcCtD
Boceprevir—Eosinophilia—Lisinopril—dilated cardiomyopathy	0.00127	0.00355	CcSEcCtD
Boceprevir—Pruritus—Spironolactone—dilated cardiomyopathy	0.00127	0.00354	CcSEcCtD
Boceprevir—Pancreatitis—Lisinopril—dilated cardiomyopathy	0.00126	0.00352	CcSEcCtD
Boceprevir—CTSV—Extracellular matrix organization—ITGB1—dilated cardiomyopathy	0.00125	0.00451	CbGpPWpGaD
Boceprevir—CTSL—Extracellular matrix organization—ITGB1—dilated cardiomyopathy	0.00125	0.00451	CbGpPWpGaD
Boceprevir—Angiopathy—Furosemide—dilated cardiomyopathy	0.00124	0.00347	CcSEcCtD
Boceprevir—Immune system disorder—Furosemide—dilated cardiomyopathy	0.00124	0.00346	CcSEcCtD
Boceprevir—Bronchitis—Lisinopril—dilated cardiomyopathy	0.00124	0.00345	CcSEcCtD
Boceprevir—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00123	0.00342	CcSEcCtD
Boceprevir—Arrhythmia—Furosemide—dilated cardiomyopathy	0.00123	0.00342	CcSEcCtD
Boceprevir—Pancytopenia—Lisinopril—dilated cardiomyopathy	0.00122	0.00341	CcSEcCtD
Boceprevir—CTSS—Toll-Like Receptors Cascades—CD36—dilated cardiomyopathy	0.0012	0.00433	CbGpPWpGaD
Boceprevir—Dysuria—Lisinopril—dilated cardiomyopathy	0.0012	0.00335	CcSEcCtD
Boceprevir—Neutropenia—Lisinopril—dilated cardiomyopathy	0.0012	0.00335	CcSEcCtD
Boceprevir—Erythema—Furosemide—dilated cardiomyopathy	0.00119	0.00333	CcSEcCtD
Boceprevir—Malnutrition—Furosemide—dilated cardiomyopathy	0.00119	0.00333	CcSEcCtD
Boceprevir—Dizziness—Spironolactone—dilated cardiomyopathy	0.00118	0.00331	CcSEcCtD
Boceprevir—Erectile dysfunction—Lisinopril—dilated cardiomyopathy	0.00118	0.0033	CcSEcCtD
Boceprevir—Flatulence—Furosemide—dilated cardiomyopathy	0.00118	0.00328	CcSEcCtD
Boceprevir—Photosensitivity reaction—Lisinopril—dilated cardiomyopathy	0.00117	0.00327	CcSEcCtD
Boceprevir—Dysgeusia—Furosemide—dilated cardiomyopathy	0.00117	0.00326	CcSEcCtD
Boceprevir—CMA1—Extracellular matrix organization—ITGB1—dilated cardiomyopathy	0.00116	0.00419	CbGpPWpGaD
Boceprevir—Weight decreased—Lisinopril—dilated cardiomyopathy	0.00116	0.00325	CcSEcCtD
Boceprevir—Hyperglycaemia—Lisinopril—dilated cardiomyopathy	0.00116	0.00324	CcSEcCtD
Boceprevir—Pneumonia—Lisinopril—dilated cardiomyopathy	0.00115	0.00322	CcSEcCtD
Boceprevir—Muscle spasms—Furosemide—dilated cardiomyopathy	0.00115	0.0032	CcSEcCtD
Boceprevir—Depression—Lisinopril—dilated cardiomyopathy	0.00114	0.00319	CcSEcCtD
Boceprevir—Vomiting—Spironolactone—dilated cardiomyopathy	0.00114	0.00318	CcSEcCtD
Boceprevir—Stevens-Johnson syndrome—Lisinopril—dilated cardiomyopathy	0.00114	0.00317	CcSEcCtD
Boceprevir—Rash—Spironolactone—dilated cardiomyopathy	0.00113	0.00315	CcSEcCtD
Boceprevir—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00113	0.00315	CcSEcCtD
Boceprevir—Vision blurred—Furosemide—dilated cardiomyopathy	0.00113	0.00314	CcSEcCtD
Boceprevir—Neuropathy peripheral—Lisinopril—dilated cardiomyopathy	0.00112	0.00314	CcSEcCtD
Boceprevir—Headache—Spironolactone—dilated cardiomyopathy	0.00112	0.00313	CcSEcCtD
Boceprevir—ABCB1—heart—dilated cardiomyopathy	0.00112	0.0103	CbGeAlD
Boceprevir—Urinary tract infection—Lisinopril—dilated cardiomyopathy	0.00111	0.00311	CcSEcCtD
Boceprevir—CTSL—Class I MHC mediated antigen processing & presentation—CD36—dilated cardiomyopathy	0.00111	0.00399	CbGpPWpGaD
Boceprevir—CTSV—Class I MHC mediated antigen processing & presentation—CD36—dilated cardiomyopathy	0.00111	0.00399	CbGpPWpGaD
Boceprevir—Anaemia—Furosemide—dilated cardiomyopathy	0.0011	0.00308	CcSEcCtD
Boceprevir—Agitation—Furosemide—dilated cardiomyopathy	0.0011	0.00306	CcSEcCtD
Boceprevir—Hepatobiliary disease—Lisinopril—dilated cardiomyopathy	0.00108	0.00303	CcSEcCtD
Boceprevir—Epistaxis—Lisinopril—dilated cardiomyopathy	0.00108	0.00302	CcSEcCtD
Boceprevir—Sinusitis—Lisinopril—dilated cardiomyopathy	0.00108	0.003	CcSEcCtD
Boceprevir—Vertigo—Furosemide—dilated cardiomyopathy	0.00107	0.00299	CcSEcCtD
Boceprevir—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.00107	0.00299	CcSEcCtD
Boceprevir—Leukopenia—Furosemide—dilated cardiomyopathy	0.00107	0.00298	CcSEcCtD
Boceprevir—Nausea—Spironolactone—dilated cardiomyopathy	0.00106	0.00297	CcSEcCtD
Boceprevir—CTSK—Extracellular matrix organization—ITGB1—dilated cardiomyopathy	0.00104	0.00374	CbGpPWpGaD
Boceprevir—Rhinitis—Lisinopril—dilated cardiomyopathy	0.00103	0.00288	CcSEcCtD
Boceprevir—CMA1—Signaling by SCF-KIT—RAF1—dilated cardiomyopathy	0.00103	0.00369	CbGpPWpGaD
Boceprevir—Pharyngitis—Lisinopril—dilated cardiomyopathy	0.00102	0.00285	CcSEcCtD
Boceprevir—Urinary tract disorder—Lisinopril—dilated cardiomyopathy	0.00102	0.00284	CcSEcCtD
Boceprevir—Oedema peripheral—Lisinopril—dilated cardiomyopathy	0.00101	0.00283	CcSEcCtD
Boceprevir—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.00101	0.00282	CcSEcCtD
Boceprevir—Urethral disorder—Lisinopril—dilated cardiomyopathy	0.00101	0.00281	CcSEcCtD
Boceprevir—Dry mouth—Furosemide—dilated cardiomyopathy	0.000994	0.00277	CcSEcCtD
Boceprevir—Confusional state—Furosemide—dilated cardiomyopathy	0.000983	0.00274	CcSEcCtD
Boceprevir—Erythema multiforme—Lisinopril—dilated cardiomyopathy	0.000973	0.00272	CcSEcCtD
Boceprevir—Tinnitus—Lisinopril—dilated cardiomyopathy	0.00096	0.00268	CcSEcCtD
Boceprevir—Shock—Furosemide—dilated cardiomyopathy	0.000959	0.00268	CcSEcCtD
Boceprevir—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.000956	0.00267	CcSEcCtD
Boceprevir—Flushing—Lisinopril—dilated cardiomyopathy	0.000955	0.00267	CcSEcCtD
Boceprevir—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.000954	0.00266	CcSEcCtD
Boceprevir—Skin disorder—Furosemide—dilated cardiomyopathy	0.000947	0.00264	CcSEcCtD
Boceprevir—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.000942	0.00263	CcSEcCtD
Boceprevir—Angiopathy—Lisinopril—dilated cardiomyopathy	0.000934	0.00261	CcSEcCtD
Boceprevir—Mediastinal disorder—Lisinopril—dilated cardiomyopathy	0.000928	0.00259	CcSEcCtD
Boceprevir—Chills—Lisinopril—dilated cardiomyopathy	0.000923	0.00258	CcSEcCtD
Boceprevir—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.000919	0.00257	CcSEcCtD
Boceprevir—Hypotension—Furosemide—dilated cardiomyopathy	0.000911	0.00254	CcSEcCtD
Boceprevir—Alopecia—Lisinopril—dilated cardiomyopathy	0.000909	0.00254	CcSEcCtD
Boceprevir—Mental disorder—Lisinopril—dilated cardiomyopathy	0.000902	0.00252	CcSEcCtD
Boceprevir—Malnutrition—Lisinopril—dilated cardiomyopathy	0.000896	0.0025	CcSEcCtD
Boceprevir—Erythema—Lisinopril—dilated cardiomyopathy	0.000896	0.0025	CcSEcCtD
Boceprevir—Flatulence—Lisinopril—dilated cardiomyopathy	0.000883	0.00246	CcSEcCtD
Boceprevir—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.000877	0.00245	CcSEcCtD
Boceprevir—Paraesthesia—Furosemide—dilated cardiomyopathy	0.000875	0.00244	CcSEcCtD
Boceprevir—Back pain—Lisinopril—dilated cardiomyopathy	0.000867	0.00242	CcSEcCtD
Boceprevir—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.000861	0.0024	CcSEcCtD
Boceprevir—CTSS—Extracellular matrix organization—ITGB1—dilated cardiomyopathy	0.000855	0.00308	CbGpPWpGaD
Boceprevir—Decreased appetite—Furosemide—dilated cardiomyopathy	0.000847	0.00236	CcSEcCtD
Boceprevir—Vision blurred—Lisinopril—dilated cardiomyopathy	0.000844	0.00236	CcSEcCtD
Boceprevir—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.000841	0.00235	CcSEcCtD
Boceprevir—Fatigue—Furosemide—dilated cardiomyopathy	0.00084	0.00234	CcSEcCtD
Boceprevir—Pain—Furosemide—dilated cardiomyopathy	0.000833	0.00233	CcSEcCtD
Boceprevir—Constipation—Furosemide—dilated cardiomyopathy	0.000833	0.00233	CcSEcCtD
Boceprevir—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.000831	0.00232	CcSEcCtD
Boceprevir—Anaemia—Lisinopril—dilated cardiomyopathy	0.000828	0.00231	CcSEcCtD
Boceprevir—Angioedema—Lisinopril—dilated cardiomyopathy	0.000819	0.00228	CcSEcCtD
Boceprevir—Malaise—Lisinopril—dilated cardiomyopathy	0.000808	0.00225	CcSEcCtD
Boceprevir—Vertigo—Lisinopril—dilated cardiomyopathy	0.000805	0.00225	CcSEcCtD
Boceprevir—Syncope—Lisinopril—dilated cardiomyopathy	0.000803	0.00224	CcSEcCtD
Boceprevir—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.000803	0.00224	CcSEcCtD
Boceprevir—Leukopenia—Lisinopril—dilated cardiomyopathy	0.000802	0.00224	CcSEcCtD
Boceprevir—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.000797	0.00222	CcSEcCtD
Boceprevir—Palpitations—Lisinopril—dilated cardiomyopathy	0.000792	0.00221	CcSEcCtD
Boceprevir—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.000787	0.0022	CcSEcCtD
Boceprevir—Cough—Lisinopril—dilated cardiomyopathy	0.000782	0.00218	CcSEcCtD
Boceprevir—Urticaria—Furosemide—dilated cardiomyopathy	0.000774	0.00216	CcSEcCtD
Boceprevir—Abdominal pain—Furosemide—dilated cardiomyopathy	0.00077	0.00215	CcSEcCtD
Boceprevir—Body temperature increased—Furosemide—dilated cardiomyopathy	0.00077	0.00215	CcSEcCtD
Boceprevir—CMA1—Metabolism of proteins—LMNA—dilated cardiomyopathy	0.000764	0.00275	CbGpPWpGaD
Boceprevir—Arthralgia—Lisinopril—dilated cardiomyopathy	0.000763	0.00213	CcSEcCtD
Boceprevir—Chest pain—Lisinopril—dilated cardiomyopathy	0.000763	0.00213	CcSEcCtD
Boceprevir—Myalgia—Lisinopril—dilated cardiomyopathy	0.000763	0.00213	CcSEcCtD
Boceprevir—Anxiety—Lisinopril—dilated cardiomyopathy	0.00076	0.00212	CcSEcCtD
Boceprevir—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.000758	0.00211	CcSEcCtD
Boceprevir—CTSS—Class I MHC mediated antigen processing & presentation—CD36—dilated cardiomyopathy	0.000757	0.00272	CbGpPWpGaD
Boceprevir—Discomfort—Lisinopril—dilated cardiomyopathy	0.000754	0.0021	CcSEcCtD
Boceprevir—Dry mouth—Lisinopril—dilated cardiomyopathy	0.000746	0.00208	CcSEcCtD
Boceprevir—Confusional state—Lisinopril—dilated cardiomyopathy	0.000737	0.00206	CcSEcCtD
Boceprevir—Infection—Lisinopril—dilated cardiomyopathy	0.000726	0.00203	CcSEcCtD
Boceprevir—Shock—Lisinopril—dilated cardiomyopathy	0.000719	0.00201	CcSEcCtD
Boceprevir—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.000718	0.002	CcSEcCtD
Boceprevir—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.000716	0.002	CcSEcCtD
Boceprevir—Tachycardia—Lisinopril—dilated cardiomyopathy	0.000714	0.00199	CcSEcCtD
Boceprevir—Skin disorder—Lisinopril—dilated cardiomyopathy	0.00071	0.00198	CcSEcCtD
Boceprevir—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.000707	0.00197	CcSEcCtD
Boceprevir—CMA1—Signaling by SCF-KIT—EGFR—dilated cardiomyopathy	0.000703	0.00253	CbGpPWpGaD
Boceprevir—Asthenia—Furosemide—dilated cardiomyopathy	0.000699	0.00195	CcSEcCtD
Boceprevir—Pruritus—Furosemide—dilated cardiomyopathy	0.000689	0.00192	CcSEcCtD
Boceprevir—Hypotension—Lisinopril—dilated cardiomyopathy	0.000683	0.00191	CcSEcCtD
Boceprevir—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000667	0.00186	CcSEcCtD
Boceprevir—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.000666	0.00186	CcSEcCtD
Boceprevir—Insomnia—Lisinopril—dilated cardiomyopathy	0.000661	0.00185	CcSEcCtD
Boceprevir—CMA1—Metabolism of proteins—ACE—dilated cardiomyopathy	0.00066	0.00237	CbGpPWpGaD
Boceprevir—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.000657	0.00183	CcSEcCtD
Boceprevir—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.000652	0.00182	CcSEcCtD
Boceprevir—Dizziness—Furosemide—dilated cardiomyopathy	0.000644	0.0018	CcSEcCtD
Boceprevir—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.000644	0.0018	CcSEcCtD
Boceprevir—CTSV—Adaptive Immune System—ITGB1—dilated cardiomyopathy	0.000644	0.00232	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—ITGB1—dilated cardiomyopathy	0.000644	0.00232	CbGpPWpGaD
Boceprevir—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.000636	0.00177	CcSEcCtD
Boceprevir—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.000631	0.00176	CcSEcCtD
Boceprevir—Fatigue—Lisinopril—dilated cardiomyopathy	0.00063	0.00176	CcSEcCtD
Boceprevir—Pain—Lisinopril—dilated cardiomyopathy	0.000625	0.00174	CcSEcCtD
Boceprevir—Constipation—Lisinopril—dilated cardiomyopathy	0.000625	0.00174	CcSEcCtD
Boceprevir—Vomiting—Furosemide—dilated cardiomyopathy	0.00062	0.00173	CcSEcCtD
Boceprevir—Rash—Furosemide—dilated cardiomyopathy	0.000614	0.00171	CcSEcCtD
Boceprevir—Dermatitis—Furosemide—dilated cardiomyopathy	0.000614	0.00171	CcSEcCtD
Boceprevir—Headache—Furosemide—dilated cardiomyopathy	0.000611	0.0017	CcSEcCtD
Boceprevir—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.000603	0.00168	CcSEcCtD
Boceprevir—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.000598	0.00167	CcSEcCtD
Boceprevir—Urticaria—Lisinopril—dilated cardiomyopathy	0.000581	0.00162	CcSEcCtD
Boceprevir—Nausea—Furosemide—dilated cardiomyopathy	0.000579	0.00162	CcSEcCtD
Boceprevir—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.000578	0.00161	CcSEcCtD
Boceprevir—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.000578	0.00161	CcSEcCtD
Boceprevir—CTSL—Innate Immune System—CD36—dilated cardiomyopathy	0.000572	0.00206	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—CD36—dilated cardiomyopathy	0.000572	0.00206	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—CD36—dilated cardiomyopathy	0.000549	0.00198	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—CD36—dilated cardiomyopathy	0.000549	0.00198	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—RAC1—dilated cardiomyopathy	0.000539	0.00194	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—RAC1—dilated cardiomyopathy	0.000539	0.00194	CbGpPWpGaD
Boceprevir—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.000539	0.0015	CcSEcCtD
Boceprevir—CTSK—Adaptive Immune System—ITGB1—dilated cardiomyopathy	0.000533	0.00192	CbGpPWpGaD
Boceprevir—Asthenia—Lisinopril—dilated cardiomyopathy	0.000525	0.00146	CcSEcCtD
Boceprevir—CTSL—Adaptive Immune System—RAC1—dilated cardiomyopathy	0.000517	0.00186	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—RAC1—dilated cardiomyopathy	0.000517	0.00186	CbGpPWpGaD
Boceprevir—Pruritus—Lisinopril—dilated cardiomyopathy	0.000517	0.00144	CcSEcCtD
Boceprevir—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.0005	0.0014	CcSEcCtD
Boceprevir—Dizziness—Lisinopril—dilated cardiomyopathy	0.000484	0.00135	CcSEcCtD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	0.00048	0.00173	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—CD36—dilated cardiomyopathy	0.000474	0.0017	CbGpPWpGaD
Boceprevir—Vomiting—Lisinopril—dilated cardiomyopathy	0.000465	0.0013	CcSEcCtD
Boceprevir—Rash—Lisinopril—dilated cardiomyopathy	0.000461	0.00129	CcSEcCtD
Boceprevir—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000461	0.00129	CcSEcCtD
Boceprevir—Headache—Lisinopril—dilated cardiomyopathy	0.000458	0.00128	CcSEcCtD
Boceprevir—CTSK—Adaptive Immune System—CD36—dilated cardiomyopathy	0.000455	0.00164	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—RAC1—dilated cardiomyopathy	0.000446	0.00161	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—ITGB1—dilated cardiomyopathy	0.000439	0.00158	CbGpPWpGaD
Boceprevir—Nausea—Lisinopril—dilated cardiomyopathy	0.000434	0.00121	CcSEcCtD
Boceprevir—CTSK—Adaptive Immune System—RAC1—dilated cardiomyopathy	0.000429	0.00154	CbGpPWpGaD
Boceprevir—CMA1—Metabolism of proteins—AGT—dilated cardiomyopathy	0.000418	0.0015	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—AGTR1—dilated cardiomyopathy	0.000404	0.00145	CbGpPWpGaD
Boceprevir—CTSV—Immune System—ITGB1—dilated cardiomyopathy	0.00039	0.0014	CbGpPWpGaD
Boceprevir—CTSL—Immune System—ITGB1—dilated cardiomyopathy	0.00039	0.0014	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—CD36—dilated cardiomyopathy	0.00039	0.0014	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000375	0.00135	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—CD36—dilated cardiomyopathy	0.000375	0.00135	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—RAC1—dilated cardiomyopathy	0.000368	0.00132	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—RAF1—dilated cardiomyopathy	0.000357	0.00129	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—RAF1—dilated cardiomyopathy	0.000357	0.00129	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—RAC1—dilated cardiomyopathy	0.000353	0.00127	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—RAF1—dilated cardiomyopathy	0.000343	0.00123	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—RAF1—dilated cardiomyopathy	0.000343	0.00123	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—IL10—dilated cardiomyopathy	0.000338	0.00122	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000333	0.0012	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000333	0.0012	CbGpPWpGaD
Boceprevir—CTSV—Immune System—CD36—dilated cardiomyopathy	0.000333	0.0012	CbGpPWpGaD
Boceprevir—CTSL—Immune System—CD36—dilated cardiomyopathy	0.000333	0.0012	CbGpPWpGaD
Boceprevir—CTSK—Immune System—ITGB1—dilated cardiomyopathy	0.000323	0.00116	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—FASLG—dilated cardiomyopathy	0.000315	0.00113	CbGpPWpGaD
Boceprevir—CTSL—Immune System—RAC1—dilated cardiomyopathy	0.000314	0.00113	CbGpPWpGaD
Boceprevir—CTSV—Immune System—RAC1—dilated cardiomyopathy	0.000314	0.00113	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.00031	0.00111	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—FAS—dilated cardiomyopathy	0.000303	0.00109	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.0003	0.00108	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—RAF1—dilated cardiomyopathy	0.000296	0.00107	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—RAF1—dilated cardiomyopathy	0.000284	0.00102	CbGpPWpGaD
Boceprevir—CTSK—Immune System—CD36—dilated cardiomyopathy	0.000276	0.000993	CbGpPWpGaD
Boceprevir—CTSS—Immune System—ITGB1—dilated cardiomyopathy	0.000266	0.000959	CbGpPWpGaD
Boceprevir—CTSK—Immune System—RAC1—dilated cardiomyopathy	0.00026	0.000936	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000256	0.000922	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—EGFR—dilated cardiomyopathy	0.000245	0.000882	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—EGFR—dilated cardiomyopathy	0.000245	0.000882	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—RAF1—dilated cardiomyopathy	0.000244	0.000877	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000243	0.000874	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—EGFR—dilated cardiomyopathy	0.000235	0.000847	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—EGFR—dilated cardiomyopathy	0.000235	0.000847	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—RAF1—dilated cardiomyopathy	0.000234	0.000842	CbGpPWpGaD
Boceprevir—CTSS—Immune System—CD36—dilated cardiomyopathy	0.000227	0.000818	CbGpPWpGaD
Boceprevir—CTSS—Immune System—RAC1—dilated cardiomyopathy	0.000214	0.000771	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000209	0.000751	CbGpPWpGaD
Boceprevir—CTSV—Immune System—RAF1—dilated cardiomyopathy	0.000208	0.000749	CbGpPWpGaD
Boceprevir—CTSL—Immune System—RAF1—dilated cardiomyopathy	0.000208	0.000749	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—EGFR—dilated cardiomyopathy	0.000203	0.000731	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000196	0.000705	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—EGFR—dilated cardiomyopathy	0.000195	0.000702	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000191	0.000686	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000191	0.000686	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000189	0.000679	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—AGT—dilated cardiomyopathy	0.00018	0.000649	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000177	0.000637	CbGpPWpGaD
Boceprevir—CTSK—Immune System—RAF1—dilated cardiomyopathy	0.000172	0.00062	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—ANKRD1—dilated cardiomyopathy	0.000171	0.000614	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—EGFR—dilated cardiomyopathy	0.000167	0.000602	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—EGFR—dilated cardiomyopathy	0.000161	0.000578	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—TAZ—dilated cardiomyopathy	0.00016	0.000577	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	0.000155	0.000559	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	0.00015	0.000539	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	0.000147	0.000528	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—SDHA—dilated cardiomyopathy	0.000145	0.000522	CbGpPWpGaD
Boceprevir—CTSV—Immune System—EGFR—dilated cardiomyopathy	0.000143	0.000513	CbGpPWpGaD
Boceprevir—CTSL—Immune System—EGFR—dilated cardiomyopathy	0.000143	0.000513	CbGpPWpGaD
Boceprevir—CTSS—Immune System—RAF1—dilated cardiomyopathy	0.000142	0.000511	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—TNF—dilated cardiomyopathy	0.000129	0.000463	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ANKRD1—dilated cardiomyopathy	0.000129	0.000463	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000125	0.00045	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—TAZ—dilated cardiomyopathy	0.000121	0.000436	CbGpPWpGaD
Boceprevir—CTSK—Immune System—EGFR—dilated cardiomyopathy	0.000118	0.000425	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—SDHA—dilated cardiomyopathy	0.000109	0.000394	CbGpPWpGaD
Boceprevir—CTSS—Immune System—EGFR—dilated cardiomyopathy	9.74e-05	0.00035	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	9.73e-05	0.00035	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—EGFR—dilated cardiomyopathy	8.58e-05	0.000309	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	7.93e-05	0.000285	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	7.46e-05	0.000268	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	6.74e-05	0.000243	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	6.67e-05	0.00024	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	6.35e-05	0.000229	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—GPX1—dilated cardiomyopathy	3.94e-05	0.000142	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	3.86e-05	0.000139	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CD36—dilated cardiomyopathy	3.84e-05	0.000138	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—AGT—dilated cardiomyopathy	3.46e-05	0.000124	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—GPX1—dilated cardiomyopathy	2.97e-05	0.000107	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CD36—dilated cardiomyopathy	2.9e-05	0.000104	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—AGT—dilated cardiomyopathy	2.61e-05	9.38e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	1.83e-05	6.59e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	1.78e-05	6.42e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	1.61e-05	5.78e-05	CbGpPWpGaD
